LBF20406PG02: Difference between revisions
No edit summary |
No edit summary |
||
| (20 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
{{Metabolite | {{Metabolite | ||
|LipidBank=XPR1766 | |LipidBank=XPR1766 | ||
|LipidMaps= | |LipidMaps=- | ||
|SysName= 11- | |SysName=11-Oxo-prosta- (cis-5,9,trans-12,cis-14) -tetraen-1-oic acid | ||
|Common Name=&& 15-deoxy-Delta^{12.14}-Prostaglandin | |Common Name=&&15-deoxy-Delta^{12.14}- Prostaglandin J_2&&11-Oxo-prosta- (5Z,9,12E,14Z) -tetraen-1-oic acid&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity= 15-deoxy- Delta ^{12.14}-Prostaglandin J2 induces lipogenesis and adipocyte differentiation in cultured cell line.[[Reference:Kliewer_SA:Lenhard_JM:Willson_TM:Patel_I:Morris_DC:Lehmann_JM:,Cell,1995,83,813|{{RelationTable/GetFirstAuthor|Reference:Kliewer_SA:Lenhard_JM:Willson_TM:Patel_I:Morris_DC:Lehmann_JM:,Cell,1995,83,813}}]] 15-deoxy- Delta ^{12.14}-Prostaglandin J2 shows powerful proapoptotic effects by inhibiting I kappa B alpha degradation.[[Reference:Ward_C:Dransfield_I:Murray_J:Farrow_SN:Haslett_C:Rossi_AG:,J. Immunol.,2002,168,6232|{{RelationTable/GetFirstAuthor|Reference:Ward_C:Dransfield_I:Murray_J:Farrow_SN:Haslett_C:Rossi_AG:,J. Immunol.,2002,168,6232}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | |||
Latest revision as of 00:53, 10 November 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1766 |
| LipidMaps | - |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20406PG02 |
| 15-deoxy-Δ12.14- Prostaglandin J2 | |
|---|---|
| |
| Structural Information | |
| 11-Oxo-prosta- (cis-5,9,trans-12,cis-14) -tetraen-1-oic acid | |
| |
| Formula | C20H28O3 |
| Exact Mass | 316.203844762 |
| Average Mass | 316.43452 |
| SMILES | C(CC=CC=C(C(=O)1)[C@@H](CC=CCCCC(O)=O)C=C1)CCC |
| Physicochemical Information | |
| 15-deoxy- Delta ^{12.14}-Prostaglandin J2 induces lipogenesis and adipocyte differentiation in cultured cell line. Kliewer_SA et al. 15-deoxy- Delta ^{12.14}-Prostaglandin J2 shows powerful proapoptotic effects by inhibiting I kappa B alpha degradation. Ward_C et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
